Skip to main content
. 2019 Aug 20;14(8):e0220988. doi: 10.1371/journal.pone.0220988

Fig 4. Kaplan Meier estimates of progression-free survival in the intention-to-treat population of the metaanalysis on metronomic oral vinorelbine in non-small cell lung cancer.

Fig 4